Citation Impact
Citing Papers
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer
2017
The CDK4/6 Inhibitor LY2835219 Overcomes Vemurafenib Resistance Resulting from MAPK Reactivation and Cyclin D1 Upregulation
2014
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
NELL-1 in the treatment of osteoporotic bone loss
2015
Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta
2012
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
2017
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
2017
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
2016 Standout
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Bone grafts and biomaterials substitutes for bone defect repair: A review
2017 Standout
Breast cancer
2019 Standout
Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice
2023 StandoutNobel
The Pharmacological Potential of Rutin
2016 Standout
Bone regeneration: current concepts and future directions
2011 Standout
HIF-independent synthetic lethality between CDK4/6 inhibition and VHL loss across species
2019 StandoutNobel
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary
2016
Fracture healing: mechanisms and interventions
2014 Standout
Osteoporosis
2019 Standout
Building bone to reverse osteoporosis and repair fractures
2008
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Essential role of RSK2 in c-Fos–dependent osteosarcoma development
2005
A New Selective Estrogen Receptor Modulator with Potent Uterine Antagonist Activity, Agonist Activity in Bone, and Minimal Ovarian Stimulation
2005
Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
2015
Osteoporosis: now and the future
2011 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Parathyroid Hormone as an Anabolic Skeletal Therapy
2005
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
PTH analogues and osteoporotic fractures
2010
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Stimuli-responsive nanocarriers for delivery of bone therapeutics – Barriers and progresses
2018
PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase‐3β in osteoblastic Saos‐2 cells
2007 StandoutNobel
Extracellular matrix structure
2015 Standout
Enhancement of Experimental Fracture-Healing by Systemic Administration of Recombinant Human Parathyroid Hormone (PTH 1-34)
2005
Wnt signaling as a therapeutic target for bone diseases
2009
Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
2011
Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action
2021
TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
2012 Standout
Potential new drug targets for osteoporosis
2008
Antiresorptives and Osteonecrosis of the Jaw
2012
Néstor–Guillermo progeria syndrome: A novel premature aging condition with early onset and chronic development caused by BANF1 mutations
2011
Self-amplifying RNA vaccines for infectious diseases
2020
The Hallmarks of Aging
2013 Standout
The PI3K Pathway in Human Disease
2017 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Annotation: Parathyroid hormone and fracture healing
2013
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives
2012
Current Concepts on the Molecular Biology of Osteosarcoma
2009
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016
2016
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
The Skeletal Response to Teriparatide Is Largely Independent of Age, Initial Bone Mineral Density, and Prevalent Vertebral Fractures in Postmenopausal Women With Osteoporosis
2003
Bone grafts: which is the ideal biomaterial?
2019
Essential role of RSK2 in c-Fos–dependent osteosarcoma development
2005
Breast Cancer Treatment
2019 Standout
Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use
2005
Early Changes in Biochemical Markers of Bone Formation Predict BMD Response to Teriparatide in Postmenopausal Women With Osteoporosis
2005
Defining a Noncarcinogenic Dose of Recombinant Human Parathyroid Hormone 1–84 in a 2-Year Study in Fischer 344 Rats
2006
Bone Grafts and Substitutes in Dentistry: A Review of Current Trends and Developments
2021 Standout
β-Arrestin-biased ligands at seven-transmembrane receptors
2007 StandoutNobel
The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma
2016
Teriparatide [Human PTH(1-34)]: 2.5 Years of Experience on the Use and Safety of the Drug for the Treatment of Osteoporosis
2006
The addition of abemaciclib to sunitinib induces regression of renal cell carcinoma xenograft tumors
2017
Targeting CDK4 and CDK6: From Discovery to Therapy
2015
Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)
2008
Molecular Pathways: Targeting the Cyclin D–CDK4/6 Axis for Cancer Treatment
2015
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Sustained Nonvertebral Fragility Fracture Risk Reduction After Discontinuation of Teriparatide Treatment
2005
An Update on Self-Amplifying mRNA Vaccine Development
2021
A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis
2002
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Works of Jamie Young being referenced
Nonclinical safety assessment of repeated administration and biodistribution of a novel rabies self-amplifying mRNA vaccine in rats
2020
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
2014
Skeletal Changes in Rats Given Daily Subcutaneous Injections of Recombinant Human Parathyroid Hormone (1-34) for 2 Years and Relevance to Human Safety
2002
Proliferative Lesions of Ovarian Granulosa Cells and Reversible Hormonal Changes Induced in Rats by a Selective Estrogen Receptor Modulator
2001
Proliferative Lesions of Ovarian Granulosa Cells and Reversible Hormonal Changes Induced in Rats by a Selective Estrogen Receptor Modulator
2001